These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12032352)
1. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Bale TL; Giordano FJ; Hickey RP; Huang Y; Nath AK; Peterson KL; Vale WW; Lee KF Proc Natl Acad Sci U S A; 2002 May; 99(11):7734-9. PubMed ID: 12032352 [TBL] [Abstract][Full Text] [Related]
2. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Bale TL; Giordano FJ; Vale WW Trends Cardiovasc Med; 2003 Feb; 13(2):68-71. PubMed ID: 12586442 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Wang H; Keiser JA Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730 [TBL] [Abstract][Full Text] [Related]
4. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. Korff T; Kimmina S; Martiny-Baron G; Augustin HG FASEB J; 2001 Feb; 15(2):447-57. PubMed ID: 11156960 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Goto F; Goto K; Weindel K; Folkman J Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443 [TBL] [Abstract][Full Text] [Related]
13. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Takeshita S; Rossow ST; Kearney M; Zheng LP; Bauters C; Bunting S; Ferrara N; Symes JF; Isner JM Am J Pathol; 1995 Dec; 147(6):1649-60. PubMed ID: 7495290 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
16. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Miura S; Matsuo Y; Saku K Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712 [TBL] [Abstract][Full Text] [Related]
17. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. O'Connor DS; Schechner JS; Adida C; Mesri M; Rothermel AL; Li F; Nath AK; Pober JS; Altieri DC Am J Pathol; 2000 Feb; 156(2):393-8. PubMed ID: 10666367 [TBL] [Abstract][Full Text] [Related]
18. VEGF spatially directs angiogenesis during metanephric development in vitro. Tufró A Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Montesano R; Kumar S; Orci L; Pepper MS Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]